Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 14, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$6.27B
sum of reported positions
Reported positions
833
Changes vs prior quarter
994
141 new · 267 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 299 measured positions in 6 quarters, the typical new or larger position finished −3.3 pts against the S&P 500 and 39% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 1.05M | $146M | 2.3% | |
| 333K | $83.8M | 1.3% | |
| 223K | $76.6M | 1.2% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $6.73B | $6.27B |
| Positions | 959 | 833 |
| Biggest line | — | Intel 2% |
| 957K |
| $74.9M |
| 1.2% |
| 403K | $73M | 1.2% |
| 696K | $71.2M | 1.1% |
| 76K | $70.7M | 1.1% |
| 176K | $69.9M | 1.1% |
| 514K | $69.6M | 1.1% |
| 922K | $68.6M | 1.1% |
| 1.66M | $68.6M | 1.1% |
| 65K | $68.2M | 1.1% |
| 396K | $66.5M | 1.1% |
| 680K | $65.3M | 1.0% |
| 236K | $65.1M | 1.0% |
| 409K | $62M | 1.0% |
| 660K | $60.5M | 1.0% |
| 571K | $59.1M | 0.9% |
| 151K | $54.8M | 0.9% |
| 849K | $54.5M | 0.9% |
| 185K | $54.3M | 0.9% |
| 1.57M | $50.2M | 0.8% |
| 642K | $49.9M | 0.8% |
| 176K | $49.9M | 0.8% |
| 268K | $48.2M | 0.8% |
Cytokinetics (CYTK)
278K → 14K shares (−95%)
Cabaletta Bio (CABA)
18K → 383K shares (+2078%)
Playtika Holding (PLTK)
496K → 319K shares (−36%)
Rayonier Advanced Materials (RYAM)
166K → 150K shares (−10%)
Teekay (TK)
123K → 118K shares (−4%)
Cto Realty Growth (CTO)
49K → 55K shares (+13%)
Anteris Technologies Global (AVR)
66K → 117K shares (+77%)
Nabors Industries (NBR)
26K → 14K shares (−46%)
Ducommun Inc (DCO)
6,683 → 6,207 shares (−7%)
Bicara Therapeutics (BCAX)
14K → 39K shares (+176%)
Equitable Holdings (EQH)
26K shares
Oil-Dri Corp of America (ODC)
6,380 → 11K shares (+75%)
Rocket Pharmaceuticals (RCKT)
261K → 332K shares (+27%)
Maravai Lifesciences Holdings (MRVI)
229K → 181K shares (−21%)
Harmonic Inc. (HLIT)
121K → 66K shares (−46%)
Fuelcell Energy (FCEL)
42K → 30K shares (−29%)
Solid Biosciences (SLDB)
198K → 107K shares (−46%)
Tandem Diabetes Care (TNDM)
206K → 69K shares (−67%)
Cincinnati Financial (CINF)
13K → 5,592 shares (−58%)
Unitil Corporation (UTL)
16K → 20K shares (+23%)
Chesapeake Utilities Corp. (CPK)
2,086 → 8,392 shares (+302%)
OneSpaWorld Holdings Limited (OSW)
35K → 36K shares (+4%)
Frontier Group Holdings (ULCC)
310K → 128K shares (−59%)
Sonos, Inc. (SONO)
168K → 75K shares (−56%)
Kura Sushi USA (KRUS)
17K shares
